FOLH1 and prostate carcinoma: PSMA expression is up to 1000-fold higher in secretory cells of prostate cancer epithelium, and is positively associated with high Gleason scores, high serum prostate-specific antigens (PSAs), advanced tumor stages, and a high likelihood of recurrence of the disease [15,16].